Literature DB >> 15161824

Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer.

Saima Aijaz1, Lynda Erskine, Glen Jeffery, Shomi S Bhattacharya, Marcela Votruba.   

Abstract

PURPOSE: Autosomal dominant optic atrophy (ADOA) is characterized by primary degeneration of retinal ganglion cells and atrophy of the optic nerve. The OPA1 gene encodes a 960-amino-acid protein. In the current study the temporal and spatial localization of OPA1 were examined in developing and adult murine ocular tissues and the adult human eye. Because the Bst/+ mouse has been postulated as a model of ADOA, the mOPA1 expression in the Bst/+ retina was also examined.
METHODS: A polyclonal antibody generated against a C-terminal peptide of OPA1 was used to assess by immunohistochemistry the expression of mOPA1 in the wild-type embryonic and postnatal mouse ocular tissues and the Bst/+ retina. Western blot analyses of total proteins from a panel of adult human tissues were used to examine the expression of human OPA1, and spatial localization was assessed by immunohistochemistry.
RESULTS: The ocular expression of mOPA1 begins at E15 in the inner retina in a location corresponding to that of the subsequently developing ganglion cell layer (GCL) and peaks between postnatal day (P)0 and P1 in the retina and the optic nerve. There is a sharp decline in mOPA1 expression after P2, but it is expressed at a basal level until at least P12 in the GCL, inner plexiform layer (IPL), and inner nuclear layer (INL) of the retina as well as in the optic nerve. In the adult Bst/+ retina, mOPA1 is strongly expressed in the GCL and IPL and weakly in the INL. In the adult human eye, OPA1 is expressed in the GCL, IPL, INL, and outer plexiform layer (OPL) of the retina and in the optic nerve, where it is observed only in the myelinated region.
CONCLUSIONS: OPA1 is not restricted to the GCL of the mammalian retina, and its expression extends into the IPL, INL, and OPL. OPA1 is distinctly expressed in the myelinated region beyond the lamina cribrosa in the human optic nerve, whereas its expression is weaker in the mouse optic nerve. In the Bst/+ mouse retina, despite the structural defects, mOPA1 expression is comparable to that observed in the wild-type adult mouse retina. These observations suggest a wider role for OPA1 than previously anticipated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161824     DOI: 10.1167/iovs.03-1093

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

Review 1.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

Review 2.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

3.  OPA1 expression in the normal rat retina and optic nerve.

Authors:  Won-Kyu Ju; Takumi Misaka; Yulia Kushnareva; Saya Nakagomi; Neeraj Agarwal; Yoshihiro Kubo; Stuart A Lipton; Ella Bossy-Wetzel
Journal:  J Comp Neurol       Date:  2005-07-18       Impact factor: 3.215

4.  N-terminal cleavage of the mitochondrial fusion GTPase OPA1 occurs via a caspase-independent mechanism in cerebellar granule neurons exposed to oxidative or nitrosative stress.

Authors:  Josie J Gray; Amelia E Zommer; Ron J Bouchard; Nathan Duval; Craig Blackstone; Daniel A Linseman
Journal:  Brain Res       Date:  2012-12-07       Impact factor: 3.252

5.  OPA1, the disease gene for optic atrophy type Kjer, is expressed in the inner ear.

Authors:  Stefanie Bette; Ulrike Zimmermann; Bernd Wissinger; Marlies Knipper
Journal:  Histochem Cell Biol       Date:  2007-09-08       Impact factor: 4.304

6.  Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina.

Authors:  Won-Kyu Ju; Keun-Young Kim; Mila Angert; Karen X Duong-Polk; James D Lindsey; Mark H Ellisman; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

7.  Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve.

Authors:  Won-Kyu Ju; Keun-Young Kim; James D Lindsey; Mila Angert; Karen X Duong-Polk; Ray T Scott; James Jaeyoung Kim; Ismail Kukhmazov; Mark H Ellisman; Guy A Perkins; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-09       Impact factor: 4.799

8.  Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level.

Authors:  Aldina Reis; Catarina Mateus; Teresa Viegas; Ralph Florijn; Arthur Bergen; Eduardo Silva; Miguel Castelo-Branco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-04       Impact factor: 3.117

9.  Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity.

Authors:  Y E Kushnareva; A A Gerencser; B Bossy; W-K Ju; A D White; J Waggoner; M H Ellisman; G Perkins; E Bossy-Wetzel
Journal:  Cell Death Differ       Date:  2012-11-09       Impact factor: 15.828

10.  Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells.

Authors:  Won-Kyu Ju; Keun-Young Kim; James D Lindsey; Mila Angert; Ankur Patel; Ray T Scott; Quan Liu; Jonathan G Crowston; Mark H Ellisman; Guy A Perkins; Robert N Weinreb
Journal:  Mol Vis       Date:  2009-01-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.